Everolimus improved renal function without reducing the size of a kidney angiomyolipoma in a patient with tuberous sclerosis complex: a case report

Everolimus improved renal function without reducing the size of a kidney angiomyolipoma in a patient with tuberous sclerosis complex: a case report

Abstract Background Tuberous sclerosis complex is an autosomal dominant genetic disorder that affects multiple organ systems and can result in tumors in the brain, skin, heart, and kidneys; it may also cause neurological symptoms. About 1 to 7% of patients develop end-stage renal disease due to bila...

Full description

Bibliographic Details
Main Authors: Akira Ashida, Hideki Matsumura, Yuko Fujii, Hyogo Nakakura, Akihiko Shirasu, Hiroshi Tamai
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Renal Replacement Therapy
Subjects:
Everolimus
Tuberous sclerosis complex
Angiomyolipoma
mTOR inhibitor
Glomerular hyperfiltration
Online Access:http://link.springer.com/article/10.1186/s41100-018-0166-7

Internet

http://link.springer.com/article/10.1186/s41100-018-0166-7

Similar Items